你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能！
| 药品名称 | 剂型 | USP 溶出方法 | 转速（转/min） | 溶出介质 | 容积 | 推荐采样时间 | 更新时间 | 查看详情 |
|---|---|---|---|---|---|---|---|---|
| Apalutamide | Tablet | II (Paddle) | 75 | 0.25% sodium lauryl sulfate (SLS) in 0.05 M Sodium Phosphate Buffer, pH 4.5 (60 mg strength); 0.5% sodium lauryl sulfate (SLS) in 0.05 M Sodium Phosphate Buffer, pH 4.5 (240 mg strength) | 900 | 5, 10, 15, 20, 30, and 45 | 2024-02-16 | 查看 |
| Olaparib | Tablet | I (Basket) | 100 | 50 mM Phosphate Buffer, pH 6.8 | 900 | 15, 30, 45 and 60 | 2024-02-16 | 查看 |
| Acetaminophen; Butalbital | Capsule | Develop a dissolution method | 2024-02-05 | 查看 | ||||
| Adagrasib | Tablet | II (Paddle) | 75 | pH 6.8 phosphate buffer with 0.3% SLS | 900 | 10, 15, 30, 45 and 60 | 2024-02-05 | 查看 |
| Amoxicillin; Clarithromycin; Vonoprazan Fumarate | Capsule, Tablet, Tablet | Clarithromycin and Vonoprazan: II (Paddle) | Clarithromycin and Vonoprazan: 50 | Amoxicillin: Develop a dissolution method; Clarithromycin: 0.1M Sodium Acetate Buffer (pH 5.0); Vonoprazan: 0.05M Acetate Buffer (pH 4.5) | 900 | 10, 15, 30, 45, 60 and 90 | 2024-02-05 | 查看 |
| Amoxicillin; Vonoprazan Fumarate | Capsule, Tablet | Vonoprazan: II (Paddle) | Vonoprazan: 50 | Amoxicillin: Develop a dissolution method; Vonoprazan: 0.05M Acetate Buffer (pH 4.5) | 900 | 10, 15, 30, 45, 60 and 90 | 2024-02-05 | 查看 |
| Aprepitant | Emulsion | Develop a method to characterize in vitro release | 2024-02-05 | 查看 | ||||
| Baclofen | Granules | II (Paddle) | 50 | 0.01 N HCl | 500 | 5, 10, 15 and 30 | 2024-02-05 | 查看 |
| Caffeine; Ergotamine Tartrate | Suppository | II (Paddle) | 50 | 1% Tartaric Acid | 900 | 10, 15, 30, 35, 40 and 45 | 2024-02-05 | 查看 |
| Elagolix Sodium, Estradiol, Norethindrone Acetate; Elagolix Sodium | Capsule | Elagolix: I (Basket) | Elagolix: 100 | Elagolix: 0.05M Sodium Phosphate pH 6.8 | 10, 15, 20, 25, 30, 45, 60 and 90 | 2024-02-05 | 查看 | |
| Finasteride; Tadalafil | Capsule | Develop a dissolution method | 2024-02-05 | 查看 | ||||
| Lenacapavir Sodium | Tablet | II (Paddle) with sinkers | 75 | 30 mM potassium phosphate, pH 6.0 with 2.0% Cremophor EL | 900 | 10, 15, 20, 25, 30, 45 and 60 | 2024-02-05 | 查看 |
| Nilotinib HCl | Capsule | I (Basket) | 100 | 0.1 N HCl | 1000 | 10, 15, 20, 30 and 45 | 2024-02-05 | 查看 |
| Niraparib Tosylate | Tablet | II (Paddle) | 60 | 0.1 M Citrate buffer, pH 4.6 | 900 | 5, 10, 15, 20, 25, 30 and 45 | 2024-02-05 | 查看 |
| Olutasidenib | Capsule | II (Paddle) with sinkers | 65 | McIlvaine Buffer, pH 2.2 W/ 1.25% SDS | 500 | 10, 15, 30, 45, and 60 | 2024-02-05 | 查看 |
| Sodium Phenylbutyrate | Pellets | II (Paddle) | 75 | Simulated Intestinal Fluid without pancreatin | 900 | 5, 10, 15, 30 and 45 | 2024-02-05 | 查看 |
| Sodium Phenylbutyrate; Taurursodiol | Powder | II (Paddle) | 75 | 5 mM phosphate w/ 0.1% SDS, pH 6.8 | 900 | 5, 10, 15, 30 and 45 | 2024-02-05 | 查看 |
| Testosterone Undecanoate | Capsule | II (Paddle) | 75 | 0.01 N HCl with 0.5% Triton X 100 | 900 | 5, 10, 15, 30, 45 and 60 | 2024-02-05 | 查看 |
| Acetaminophen/Aspirin/Caffeine | Tablet | Develop a dissolution method | 2024-01-03 | 查看 | ||||
| Acetaminophen/Butalbital/Caffeine | Tablet | Develop a dissolution method | 2024-01-03 | 查看 |
